CEO received an award of 295K MDT derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 3, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 5, 2026
CEOGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001560409-26-000008
- Filed / recorded
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly Reporting personGeoffrey Martha RelationshipDirector, Officer Officer titleChairman and CEO SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateAug 3, 2026 Acquired / disposedAcquired (A) Shares owned after295,002 Footnotes from the filing
- These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Around the same time
Congress tradeSits on House Ways and Means, Health2 different filers disclosed MDT within 90 days. Disclosed 8 days after the transaction; reported as an official range, not an exact amount.
Routine share withholding; mechanical by default.
Congress trade3 different filers disclosed MDT within 90 days. Disclosed 15 days after the transaction; reported as an official range, not an exact amount.